Michael Otterstatter

10PUBLICATIONS
36CO-AUTHORS
Haematological tumoursPhysical organic chemistryPredictive and prognostic markersClinical psychologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 29, 2026
Clinical and Genomic Convergence of High-Risk CCUS and Lower-Risk Myelodysplastic Syndromes/Neoplasms.

|Feb 24, 2026
Exposure to Agent Orange and association with myelodysplastic syndromes.

Mikkael A Sekeres, Amy E DeZern, Michael Otterstatter

|Feb 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study.

Amy E DeZern, Nancy Gillis, Michael Otterstatter

|Jan 17, 2025
Opioid agonist therapy discontinuation in British Columbia: a cross-sectional study of people who access harm reduction services.

Kimia Ziafat, Lisa Liu, Bradley Kievit

|Aug 08, 2023
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies.

Edward J Gorak, Michael Otterstatter, Tareq Al Baghdadi

|May 05, 2023
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study.

Gregory A Abel, Donnie Hebert, Cecilia Lee

Pageof 2

Frequent Collaborators

5 joint publications

Nancy Gillis

4 joint publications

Rafael Bejar

4 joint publications

Rami S Komrokji

4 joint publications

Mikkael A Sekeres